Migrén: vizsgálatok itt: Románia
2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Where
- Bucharest, Bucuresti, Cluj-Napoca, Sibiu
- Életkor
- 6 év to 17 év
- People
- 450 worldwide
- Run by
- AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00 - 3. fázisCsak meghívásosLong-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Bucharest, Bucuresti, Cluj-Napoca
- Életkor
- 6 év to 17 év
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00